Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Crinetics Pharmaceuticals Inc shares valued at $195,350 were sold by Pizzuti Dana on Feb 03 ’25. At $39.07 per share, Pizzuti Dana sold 5,000 shares. The insider’s holdings dropped to 31,748 shares worth approximately $1.05 million following the completion of this transaction.
Also, DANA J PIZZUTI purchased 5,000 shares, netting a total of over 195,372 in proceeds.
Before that, Pizzuti Dana had sold 15,000 shares from its account. In a trade valued at $781,350, the Chief Med and Dev Officer traded Crinetics Pharmaceuticals Inc shares for $52.09 each. Upon closing the transaction, the insider’s holdings decreased to 15,000 shares, worth approximately $0.97 million.
As published in their initiating research note from TD Cowen on February 11, 2025, Crinetics Pharmaceuticals Inc [CRNX] has been a Buy. Analysts at Wolfe Research started covering the stock with ‘”a Peer perform”‘ outlook in a report released in early February. As of January 22, 2025, Jefferies has increased its “Hold” rating to a “Buy” for CRNX. Earlier on March 06, 2024, Citigroup initiated its rating. Their recommendation was “a Buy” for CRNX stock.
Analyzing CRNX Stock Performance
During the last five days, there has been a drop of approximately -9.90%. Over the course of the year, Crinetics Pharmaceuticals Inc shares have dropped approximately -35.05%. Shares of the company reached a 52-week high of $53.55 on 01/03/25 and a 52-week low of $31.84 on 02/25/25. A 50-day SMA is recorded $42.37, while a 200-day SMA reached $49.76. Nevertheless, trading volume fell to 0.98 million shares from 1.08 million shares the previous day.
Support And Resistance Levels for Crinetics Pharmaceuticals Inc (CRNX)
According to the 24-hour chart, there is a support level at 32.53, which, if violated, would cause prices to drop to 31.85. In the upper region, resistance lies at 33.93. The next price resistance is at 34.65. RSI (Relative Strength Index) is 32.98 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.55, which suggests the price will decrease in the coming days. Percent R is at 81.34%, indicating bearish price movement. Stochastics %K at buying indicates that the stock is to be held.
